Member of the Board since 2015.
Gunilla holds an MD, PhD and Associate Professor from Karolinska Institutet. Her wideranging experience covers all phases of drug development in small, medium and large companies. She is a co-founder of Gesynta Pharma and holds several board positions.
Holdings in the company: 88,420 shares and 190,897 employee warrants.
Independence: Gunilla is independent in relation to the company and is independent in relation to the Company’s largest shareholders.
Other Board assignments: Board member in Corline Biomedical AB, Haracon AB, Disruptive Pharma AB, Initiator Pharma A/S and Strike Pharma AB.